Neurogene
NGNE
81 hedge funds and large institutions have $330M invested in Neurogene in 2020 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 33 increasing their positions, 13 reducing their positions, and 13 closing their positions.
154% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 13
62% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 13
9% more funds holding
Funds holding: 74 → 81 (+7)
0.03% more ownership
Funds ownership: 3.27% → 3.3% (+0.03%)
21% less capital invested
Capital invested by funds: $417M → $330M (-$87.4M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
57% less call options, than puts
Call options by funds: $156K | Put options by funds: $367K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.16M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
+$5.96M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$5.14M |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$4.49M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$3.95M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$8.92M |
| 2 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
-$4.81M |
| 3 |
Renaissance Technologies
New York
|
-$2.46M |
| 4 |
Millennium Management
New York
|
-$1.64M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$1.31M |
NGNE Hedge Fund Activity: Q3 2020 in Review
81 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q3 2020, worth a combined $330M — down 21% from $417M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new NGNE positions and 13 closed out — a net gain of 8 holders — while 33 added to existing stakes and 13 trimmed.
The largest buyer was Point72 Asset Management, adding an estimated $6.16M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $8.92M sold.
- 81 institutional investors held Neurogene (NGNE) as of Q3 2020, up from 74 in Q2 2020.
- Funds reported $330M of Neurogene stock for Q3 2020, down 21% quarter-over-quarter.
- 21 funds opened new Neurogene positions in Q3 2020 and 13 closed out, a net change of +8 holders.
- The largest Neurogene buyer in Q3 2020 was Point72 Asset Management, an estimated $6.16M added.
- The largest Neurogene seller in Q3 2020 was Perceptive Advisors, an estimated $8.92M sold.
Based on aggregated 13F filings for Q3 2020.